ARAY stock news

Service revenues drive Accuray's (ARAY) Q2 results, gross margin expands. Read more
SUNNYVALE, Calif., Jan. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019. Recent Company Highlights Gross orders of $98.6 million, including 11 orders from China Net orders of… Read more
SUNNYVALE, Calif., Jan. 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30… Read more
SUNNYVALE, Calif., Jan. 8, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System provided excellent disease control with… Read more
SUNNYVALE, Calif., Jan. 6, 2020 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 10:00 a.m. PT. The… Read more
SUNNYVALE, Calif., Dec. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Stanford University Medical Center has selected a second CyberKnife® M6™ System to expand access to precise radiosurgery treatments to more of their patients. With its installation,… Read more
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing about 1%. The Russell 2000, composed of smaller companies, performed even worse, trailing the S&P by Read more
Accuray Incorporated (NASDAQ:ARAY) CEO Joshua Levine sold 28,081 shares of the company’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $2.61, for a total transaction of $73,291.41. Following the transaction, the chief executive officer now directly owns 931,063 shares in the company, valued at $2,430,074.43. The […] Read more
SUNNYVALE, Calif., Nov. 6, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Suzanne Winter, the company's new Senior Vice President, Chief Commercial Officer. As a material inducement to Ms…. Read more
SUNNYVALE, Calif., Oct. 29, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2020 ended September 30, 2019. Recent Company Highlights Gross orders increased 28 percent year over year to $78.5 million 11 orders… Read more
SUNNYVALE, Calif., Oct. 28, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) – Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system… Read more
Accuray's (ARAY) CyberKnife delivers stereotactic body radiation therapy in only five sessions. Read more
Accuray (ARAY) expects fiscal 2020 revenues to be impacted by China tariffs. Read more
Accuray (ARAY) delivered earnings and revenue surprises of -166.67% and 1.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT